CTMX - Cytomx Therapeutics, Inc.

Name: Cytomx Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Sean A. McCarthy	1.08M	$2.35M	-
VP	Marcia Belvin	300.8K	$655.7K	-
CFO	Christopher Ogden	295.3K	$643.8K	-
Other	Yu-Waye Chu	189.4K	$413.0K	-
Other	Alejandra Carvajal	100.0K	$218.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Nov 29, 2016	Timothy M Shannon82	Director	Sell	22,086	$11.18	$247,007.62	-0.7%
Nov 29, 2016	Canaan IX L.P.	Director	Sell	22,086	$11.18	$247,007.62	-0.6%
Nov 28, 2016	Timothy M Shannon82	Director	Sell	38,459	$11.56	$444,404.44	-1.0%
Nov 28, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	38,459	$11.56	$444,404.44	-1.0%
Nov 22, 2016	Timothy M Shannon82	Director	Sell	42,550	$11.71	$498,077.54	-1.1%
Nov 22, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	42,550	$11.71	$498,077.54	-1.1%
Nov 21, 2016	Timothy M Shannon82	Director	Sell	45,324	$11.61	$526,087.76	-1.2%
Nov 21, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	45,324	$11.61	$526,087.76	-1.2%
Nov 16, 2016	Timothy M Shannon82	Director	Sell	51,581	$11.50	$593,428.35	-1.3%
Nov 16, 2016	Canaan IX L.P.	Director, 10% Owner	Sell	51,581	$11.50	$593,428.35	-1.3%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC